The intersection of molecule and to treat, can promote patient

The intersection of molecule and to treat, can promote patient of neck cancer survival rate target
It is reported ' Reporter Wang XueFei) Committee, radiotherapy of Chinese Anti-Cancer Association, hold to treat the forum in Shanghai recently. The expert participating in the conference introduced, published and studied in shining on the bed in the international many centres of " medical magazine of New England " at random a few days ago - -EXTREME studies to prove, jointly uses the molecule target while putting chemotherapy to monoclonal antibody of proper former times of the west of medicine, can lengthen the neck cancer patient's total life cycle notably, survival rate is improved by 10% than the simple chemotherapy patient in the patient's 5, it is improved from 20% to 36% that the treatment is always efficient.

Neck cancer including nasopharyngeal carcinoma, laryngeal carcinoma, thyroid gland cancer,etc. has already become the sixth largest high hair cancer in the world, over 90% of the neck cancers are scale's cell cancer. The annual morbidity of neck cancer of our country has already been up to 15.22/10 Wan.

The head of the department of the radiotherapy of the intersection of U.S.A. M.D.Anderson and the intersection of tumour and in the center, U.S.A. tumour learn branch's former President KianKAng. professor of the radiotherapy how to say on the forum, about 75% of the neck scale's cell cancer patients have been already in later period or shift at the time of the visit for the first time. This kind of patient mainly accepts the condoning chemotherapy based on platinum at present, among them the location is life cycle is only about 6 months. EXTREME studies and realizes time of surviving prominent extension in scale's cell cancer of neck recurs and/or shifts a patient for the first time over the past 30 years. It's time to discover, add and use the west to resist only in proper former times on the basis of standard chemotherapy scheme based on platinum - 5FU, very prominent extension patient's existence time.

Subsidiary Deputy Director of tumour hospital radiotherapy Professor Hu ChaoSu of Fudan University says, molecule target the intersection of tumour and clinical focus of treatment at present to treat. Molecule target a target to the supreme level of treating to treat ' Another two levels are histoorgan level and cell level) . It is introduced the west resist it is in the world first that obtain target of approval to act on the intersection of epidermis and the intersection of growth factor and monoclonal antibody of receptor only former times while being proper separately, have already put into clinical practice in over 70 countries or regions at present.



The intersection of molecule and to treat, can promote patient of neck cancer survival rate target